Almost every sixth human worldwide suffers from diabetes, obesity or both. Interestingly, genetic differences can only explain a proportion of cases. A second, more enigmatic regulatory system seems to play a central role in the development of the disease: so-called ‘epi’genetic regulation.
PhD student Tess Lu and the Freiburg scientist J. Andrew Pospisilik from the Max Planck Institute of Immunobiology and Epigenetics found evidence that type-2 diabetes may result in part from insulin cells that lose their epigenetic memory, and thus, their function. For upcoming studies, Pospisilik was awarded with a Rising Star award at the conference of the European Association for the Study of Diabetes in Barcelona.
Epigenetic regulation determines gene activity in different cell types and acts as a kind of cell-type specific memory. This epigenetic memory can be modified by external factors such as diet and stress. At the same time it can remain conserved throughout many cell divisions and even generations.
In 2012, researchers unraveled a long overseen mechanism for how we develop type-2 diabetes. Rather than dying, or shutting down function, insulin producing beta-cells seemed to be “forgetting” their fate and reverting towards a more stem cell like identity. Although this idea is new, the Pospisilik group was able to recreate this unique disease pathology by controlling epigenetic state. This finding will help enable researchers around the world to investigate the new diabetes form in great detail.
The Freiburg researchers switched off the gene for an epigenetic regulator previously shown to control entire programs of cellular identity. Animals with this modification were first healthy and developed normal insulin producing cells. But at around middle-age, the cells forgot their function and the animals could not control their blood sugar anymore. The researchers did not find any hints for inflammations, cell death or cell proliferation, leaving behind ‘ghost-like’ cells with no clear markers of their former selves.
With the “rising star” award, Pospisilik aims to investigate the epigenetic profile of individual cells and find out, which epigenetic alterations in detail are involved in diabetes development. The research group will combine cellular, biochemical and analytic methods and the new data will be easily accessible for other researchers through an open access platform.
“These studies will give the diabetes community some first insights into how epigenetic profiles remain stable and why insulin producing cells forget their function,” says Pospisilik. “The research is suited to make an important contribution to fundamental concepts such as stem cell differentiation. At the same time, the research will lead to a deeper understanding of a disease that affects millions of people. It may even open new therapeutic strategies.”
J. Andrew Pospisilik was born in 1976 in Vancouver. Since 2010, he leads his own laboratory at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg.Contact:
Dr Harald Rösch | idw
Breakthrough Prize for Kim Nasmyth
04.12.2017 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH
The key to chemical transformations
29.11.2017 | Schweizerischer Nationalfonds SNF
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong
Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
13.12.2017 | Health and Medicine
13.12.2017 | Physics and Astronomy
13.12.2017 | Life Sciences